333 related articles for article (PubMed ID: 19995587)
1. Synthesis and biological evaluation of cyclic endomorphin-2 analogs.
Perlikowska R; do-Rego JC; Cravezic A; Fichna J; Wyrebska A; Toth G; Janecka A
Peptides; 2010 Feb; 31(2):339-45. PubMed ID: 19995587
[TBL] [Abstract][Full Text] [Related]
2. Redoubling the ring size of an endomorphin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic.
Piekielna J; De Marco R; Gentilucci L; Cerlesi MC; Calo' G; Tömböly C; Artali R; Janecka A
Biopolymers; 2016 May; 106(3):309-17. PubMed ID: 27038094
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.
Janecka A; Fichna J; Kruszynski R; Sasaki Y; Ambo A; Costentin J; do-Rego JC
Biochem Pharmacol; 2005 Dec; 71(1-2):188-95. PubMed ID: 16288997
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.
Perlikowska R; Piekielna J; Gentilucci L; De Marco R; Cerlesi MC; Calo G; Artali R; Tömböly C; Kluczyk A; Janecka A
Eur J Med Chem; 2016 Feb; 109():276-86. PubMed ID: 26785295
[TBL] [Abstract][Full Text] [Related]
5. Effect of 2',6'-dimethyl-L-tyrosine (Dmt) on pharmacological activity of cyclic endomorphin-2 and morphiceptin analogs.
Fichna J; Perlikowska R; Wyrębska A; Gach K; Piekielna J; do-Rego JC; Toth G; Kluczyk A; Janecki T; Janecka A
Bioorg Med Chem; 2011 Dec; 19(23):6977-81. PubMed ID: 22047797
[TBL] [Abstract][Full Text] [Related]
6. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel peripherally active morphiceptin analogs.
Gach K; do-Rego JC; Fichna J; Storr M; Delbro D; Toth G; Janecka A
Peptides; 2010 Aug; 31(8):1617-24. PubMed ID: 20434497
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of novel cyclic pentapeptides with µ-opioid receptor agonist activity.
Perlikowska R; Piekielna J; Fichna J; do-Rego JC; Toth G; Janecki T; Janecka A
Med Chem; 2014 Mar; 10(2):154-61. PubMed ID: 23628088
[TBL] [Abstract][Full Text] [Related]
9. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antinociceptive effects of endomorphin-1 analogs with C-terminal linked by oligoarginine.
Wang CL; Guo C; Wang YQ; Zhou Y; Li Q; Ni JM; Wang R
Peptides; 2011 Feb; 32(2):293-9. PubMed ID: 21055434
[TBL] [Abstract][Full Text] [Related]
11. Structure-constrained endomorphin analogs display differential antinociceptive mechanisms in mice after spinal administration.
Wang Y; Zhou J; Liu X; Zhao L; Wang Z; Zhang X; Wang K; Wang L; Wang R
Peptides; 2017 May; 91():40-48. PubMed ID: 28363796
[TBL] [Abstract][Full Text] [Related]
12. Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity.
Kruszynski R; Fichna J; do-Rego JC; Chung NN; Schiller PW; Kosson P; Costentin J; Janecka A
J Pept Res; 2005 Sep; 66(3):125-31. PubMed ID: 16083439
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues.
Perlikowska R; Malfacini D; Cerlesi MC; Calo' G; Piekielna J; Floriot L; Henry T; do-Rego JC; Tömböly C; Kluczyk A; Janecka A
Peptides; 2014 May; 55():145-50. PubMed ID: 24632335
[TBL] [Abstract][Full Text] [Related]
14. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
15. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
16. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
17. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
[TBL] [Abstract][Full Text] [Related]
18. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
[TBL] [Abstract][Full Text] [Related]
19. Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.
Szeto HH; Soong Y; Wu D; Qian X; Zhao GM
J Pharmacol Exp Ther; 2003 May; 305(2):696-702. PubMed ID: 12606628
[TBL] [Abstract][Full Text] [Related]
20. Pseudoproline-containing analogues of morphiceptin and endomorphin-2: evidence for a cis Tyr-Pro amide bond in the bioactive conformation.
Keller M; Boissard C; Patiny L; Chung NN; Lemieux C; Mutter M; Schiller PW
J Med Chem; 2001 Nov; 44(23):3896-903. PubMed ID: 11689075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
